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induced by the newly cloned C-C chemokine eotaxin
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ABSTRACT
The present study was performed in order to investigate
the mechanism(s) involved in eotaxin-induced normal
human eosinophil chemotaxis using a 48-well micro-
chemotaxis chamber assay. Eotaxin, at a wide range of
doses, induced eosinophil chemotaxis with optimal
activity at 100 ng/mL. To elucidate the role of Ca 2+ as a
second messenger, eosinophils were depleted of intra-
cellular Ca 2+ which, per se, did not modify eosinophil
chemotaxis. To gain insight of the possible intracellular
signal transduction, we blocked pertussis toxin (PTX)-
sensitive G; proteins as well as several protein kinases.
It was found that the inhibition of tyrosine kinase with
herbimycin A and the inhibition of mitogen-activated
protein kinase (MAPK) with MEK- 1 inhibitor (PD98059)
significantly blocked chemotaxis; however, inhibition of
protein kinase C with staurosporine, protein kinase A
with H-89 and G; proteins with PTX did not affect
chemotaxis. These results suggest a signal transduction
pathway(s) involving Ca 2+-independent tyrosine kinase
and MAPK activities.
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INTRODUCTION
Eosinophils are recruited in large numbers and are
thought to playa detrimental role in allergic disease. 1- 3
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Several eosinophil chemotaxins have been described;
however, eotaxin the newly cloned chemoattractant
cytokine that belongs to the ~ chemokine family, has
gained a lot of attention due to its unique property of
selectivity in attracting eosinophils, probably due to the
restricted expression of the CCR3 on the cell type." This
novel 74 amino acid C-C chemokine has been identi-
fied in guinea pig and mouse, as well as in humons.v? In
vivo, eotaxin has been reported to cause the accum-
ulation of eosinophils in the dermis of the guinea pig; in
addition, increased mRNA expression in the lungs of
postallergen-challenged sensitized guinea pigs has been
described.s,Bln vitro, activation of human eosinophils by
eotaxin involves chemotaxis, actin polymerization, Ca 2+
influx and the production of reactive oxygen species and
it has been suggested that pertussis toxin (PTX)-sensitive
G j proteins, protein kinase C (PKC), tyrosine kinase and
phosphatidyl-inositol-3-kinase were all involved in the
signal transduction of human eosinophils following
stimulation with eotoxin.? In the present in vitro study we
investigated the intracellular signals involved in eotaxin-
induced human eosinophil chemotaxis.
METHODS
Reagents
Percoll solution was purchased from Pharmacia
(Uppsala, Sweden). Herbimycin A, staurosporine, fura
2-AM and BAPTA-AM were obtained from Wako Pure
Chemical Industries (Osaka, Japan). Pertussis toxin was
purchased from Calbiochem-Novabiochem Corpor-
ation (La Jolla, CA, USA), MEK-l inhibitor was obtained
from Biolabs Inc. (New England, USA) and human
eotaxin and H-89 were purchased from Funakoshi Co.
(Tokyo, Japan).
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Eosinophil purification
Eosinophils were separated from the heparin-anti-
coagulated venous blood of healthy donors using Percoll
discontinuous density gradient centrifugation. A high
purity of > 98% eosinophilic granulocytes, as judged by
Hinkelmann staining, was obtained by negative selection
using CD- 16 immunomagnetic beads and a magnetic
cell sorting separator (Miltenyi Biotec, Bergisch Gladbach,
Gerrncnv);!" Eosinophil viability was evaluated by Trypan
blue dye exclusion and was always> 95%.
done to clarify whether eotaxin also exhibited chemo-
kinetic activity. Whenever cells migrate in response to
concentration gradients of chemotactic molecules, it is
termed chemotaxis or directed cell migration, whereas
chemokinesis represents random migration without the
requirement of concentration gradient. As can be seen in
Fig. 2, eotaxin not only showed chemotactic activity, but
also exhibited chemokinetic activity. Nonetheless, the
chemotactic activity was more significant than the
chemokinetic activity.
Fig. 1 Induction of normal human eosinophil chemotaxis by
eotaxin. Each bar represents the mean ± SEM of six
independent experiments, each performed in triplicate (P <
0.05, 10-500 ng eotaxin).
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Chemotaxis assay
Chemotaxis experiments were performed using a 48-well
microchemotaxis chamber and a 5 urn pore polycar-
bonate membrane filter, as described previously.l v'?
Briefly, 29 III of the chemotactic agent was placed in the
lower compartment of the chamber, while 50 III purified
eosinophils, suspended in RPMI 1640 containing 2% fetal
calf serum (FCS) and adjusted to 10 6 cells/ml, was placed
in the upper compartment. After incubation for 90 min at
3rC, 5% CO2, the filter was removed, fixed and stained
with Diff-Quick set (International Reagents Corp., Kobe,
Japan). As for the checkerboard assay, both the upper and
lower compartments contained different dilutions of eo-
taxin. Results of the chemotaxis experiments are expressed
as eosinophils/5 selected high power fields (5 h.pJ).
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Ca2+-depleted eosinophils
Ca 2+-depleted eosinophils were obtained by incubating
10 7 cells/ml with 30 urnol/L of the calcium chelating
agent BAPTA-AM in test medium (composition (in mmol/l):
NaCI 130; NaHC03 5; KCI 4.6; glucose 5; EGTA 2;
HEPES 20) for 30 min at 3rC in the dark. After washing
the cells, they were suspended in the Ca 2+-free buffer and
their chemotactic response against eotaxin was then tested.
Statistical analysis
Values are expressed as the mean ± SEM. Statistical
analysis was performed by analysis of variance (AN OVA)
exceptfor Fig. 3, which was analyzed by paired Student's
t-test. Statistical significance was indicated by P < 0.05.
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A wide range of doses of eotaxin attracted normal
eosinophils in modified Boyden chambers, with optimal
activity at 100 ng/ml (Fig. 1). A checkerboard assay was
Fig. 2 The checkerboard analysis of eotaxin on normal
human eosinophils. Values represent the mean of migrated
cells in triplicate filters.
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Table 1. Effect of pertussis toxin, staurosporine, H-89, MEK-1
inhibitor and herbimycin A on 100 ng/mL eotaxin-induced
eosinophil chemotaxis
Fig. 3 Comparison of the eosinophilotactic activity of 100
ng/mL eotaxin on Ca 2+ -depleted eosinophils (0) compared
with non-depleted eosinophils (.). Results are the mean ±
SEM of six different experiments performed in triplicate.
Eosinophils were pretreated with buffer, pertussis toxin (PTX) or
various kinase inhibitors for 1 h, followed by washing of the cells and
resuspension in the culture medium. Eosinophil chemotaxis against 100
ng/mL eotaxin was then tested as described in Methods. Results
represent the mean ± SEM of nine different experiments, each
performed in triplicate. tp < 0.01, *P < 0.05 compared with control
cells pretreated with buffer only.
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The newly cloned eotaxin has proven to be a very potent
and selective activator of eosinophils. In the present
study, we investigated the mechanism(s) involved in
human eosinophil directed cell migration against this
novel chemokine. In an earlier study, pretreatment of
eosinophils with PTX blocked the respiratory burst
activation of human eosinophils by eotoxin.? however, in
the present study, PTX did not modify chemotaxis,
indicating that other G protein(s) rather than the PTX-
sensitive G; protein may be involved in chemotaxis
signaling.
Staurosporine, at a dose that inhibited the respiratory
burst induced by eotaxin in human eosinophils.? and
H-89, at a dose that ensured a potent inhibitory action
against cAMP-dependent protein kincse.!" did not modify
eosinophil chemotaxis, which eliminates the possibility of
involvement of PKC and protein kinase A pathways in
eotaxin-induced eosinophil chemotaxis. Similarly, the
observation that depletion of intracellular [Ca 2+Ldid not
affect chemotaxis renders the involvement of other Ca 2+-
dependent pathways, such as phospholipase A2 and
phospholipase D, unlikely.ls,16 However, herbimycin A, the
potent tyrosine kinase inhibitor,,?,18 and MEK- 1
inhibitor19-22 significantly blocked chemotaxis. Taken
together, our results suggest the involvement of Ca 2+-
independent tyrosine kinase and mitogen-activated
protein kinase activation in eotaxin signaling for chemo-
taxis, which correlates well with the fact that phos-
phorylation of 102 and 122 kDa proteins on the tyrosine
residues of human eosinophils induced by interleukin
(IL)-5, granulocyte-macrophage colony stimulating factor
and IL-3 were Ca 2+ independent.P Nonetheless, further
studies are needed to detect protein phosphorylation
mediated by eotaxin in the presence and absence of
[Co?"]. These studies are currently underway in our
laboratory.
inhibitor resulted in a significant block of eotaxin-induced
eosinophil chemotaxis, as can be seen in Table 1. Cell
viability was checked after each treatment to rule out
cytotoxic effects and was always > 95% as judged by
Trypan blue exclusion.
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Pretreatment
The optimal dose of eotaxin induced chemotaxis of
Ca 2+-depleted eosinophils equally potently as in non-
depleted cells (Fig. 3). In depleted cells, preliminary
studies showed an initial [Ca 2+Lof 20 nmol/L, as judged
by fura 2-AM assay using the equation established by
Poenie et 01.,13 which renders the depletion assay
technically reliable (data not shown).
Eosinophil treatment with PTX, staurosporine or H-89
did not affect eosinophil chemotaxis against eotaxin;
however, treatment of cells with herbimycin A and MEK- 1
Control (buffer)
PTX (1000 ng/mL)
Staurosporine (10- 7 rnol/L)
H-89 (10- 6 mol/L)
MEK-1 inhibitor (10- 7 rnol/L)
Herbimycin A (10- 6 rnol/L)
Eosinophils/5 h.pJ
------------------
563 ± 13
567 ± 11
551 ± 45
564 ± 47
386 ± 22*
280 ± 34 t
12 A EL-SHAZLY ET AL.
REFERENCES
Gleich GJ, Flavahan NA, Fujisawa T, Vanhoutte PM. The
eosinophil as a mediator of damage to respiratory
epithelium: A model for bronchial hyperactivity. J. Allergy
C1in. Immunol. 1988; 81: 776-81.
2 Venge P, Hakansson L, Peterson CGB. Eosinophil
activation in allergic disease. Int. Arch. Allergy Appl.
Immunol. 1987; 82: 333~7.
3 Fukuda T, Gleich GJ. Heterogeneity of human eosinophils.
J. Allergy C1in. Immunol. 1989; 83: 369-72.
4 Ponath PD, Qin S, Post TW et a/. Molecular cloning and
characterization of a human eotaxin receptor expressed
selectively on eosinophils. J. Exp. Med. 1996; 183:
2437-48.
5 Jose PJ, Griffiths-Johnson DA, Collins PD et 01. Eotaxin: A
potent eosinophil chemoattractant cytokine detected in a
guinea pig model of allergic airways inflammation. J. Exp.
Med. 1994; 179: 881-7.
6 Gonzalo JA, Jia GQ, Aguirre V et 01. Mouse eotaxin
expression parallels eosinophil accumulation during lung
allergic inflammation but is not restricted to a Th2-type
response. Immunity 1996; 4: 1-14.
7 Ponath PD, Qin S, Ringler DJ et 01. Cloning of the human
eosinophil chemoattractant, eotaxin: Expression, receptor
binding and functional properties provide a mechanism for
the selective recruitment of eosinophils. J. C1in. Invest.
1996; 97: 604-12.
8 Jose PJ, Adcock 1M, Griffiths-Johnson DA et 01. Eotaxin:
Cloning of an eosinophil chemoattractant cytokine and
increased mRNA expression in allergen-challenged guinea
pig lungs. Biochem. Biophys. Res. Commun. 1994; 205:
788-94.
9 Elsner J, Hochstetter R, Kimmig D, Kapp A. Human
eotaxin represents a potent activator of the respiratory
burst of human eosinophils. Eur. J. Immunol. 1996; 26:
1919-25.
10 Hansel TT, De Vries IJ, Iff T et a/. An improved
immunomagnetic procedure for the isolation of highly
purified human blood eosinophils. J. Immunol. Methods
1991; 145: 105-10.
11 EI-Shazly AE, Masuyama K, Eura M, Ishikawa T. Immuno-
regulatory effect of substance P in human eosinophil
migratoryfunction.lmmunol.lnvest. 1996; 25: 191-201.
12 EI-ShazlyAE, Masuyama K, Samejima Y, Eura M, Ishikawa
T. Inhibition of human eosinophil chemotaxis in vitro by the
anti-allergic agent emedastine difumarate. Immuno-
pharmacal. Immunotoxicol. 1996; 18: 587-95.
13 Poenie M, Alderton J, Tsien RY, Steinhardt RA. Changes of
free calcium levels with stages of the cell division cycle.
Nature 1985; 315: 147-9.
14 Chijiwa T, Mishima A, Hagiwara M et a/. 5-lsoquinolino-
linesulfonamide (H-89), of PC12D phenochromocytoma
cells. J. Bioi. Chem. 1990; 256: 5267-72.
15 Kessels RGC, Roos D, Verhoeven AJ. fMet-Leu-Phe-
induced activation of phospholipase D in human
neutrophils. J. Bioi. Chem. 1991; 266: 23 152-6.
16 Clark JD, Lin LL, Kriz RW et a/. A novel arachidonic acid-
selective cytosolic PLA2 contains a Ca 2+-dependent
translation domain with homology to PKC and GAP. Cell
1991; 65: 1043-51.
17 Uehara Y, Fukazawa H. Use and selectivity of herbimycin A
as an inhibitor of protein tyrosine kinase. Methods
Enzymol. 1991; 201: 370-9.
18 Zeng ZM, Specter S. Dynamic production of tumour
necrosis factor-alpha messenger RNA, intracellular and
extracellular TNF-alpha by murine macrophages and
possible association with tyrosine phosphorylation of
STAT 1 alpha and ERK2 as an early signal. Immunology
1996; 87: 544-50.
19 Dudley DT, Pang L, Decker SJ, Bridges AJ, Staltiel AR.
Asynthetic inhibitor of the mitogen-activated protein kinase
cascade. Proc. Natl Acad. Sci. USA 1995; 92: 7686-9.
20 Pang L, Sawada T, Decker SJ, Saltiel AR. Inhibition of MAP
kinase blocks the differentiation of PC-12 cells induced by
nerve growth factor. J. Bioi. Chem. 1995; 270: 13 585-8.
21 Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR.
PD 098059 is a specific inhibitor of the activation of
mitogen-activated protein kinase in vitro and in vivo. J.
Bioi. Chem. 1995; 270: 27 489-94.
22 Lazar DF, Wiese RJ, Brady MJ et 01. Mitogen-activated
protein kinase inhibition does not block the stimulation of
glucose utilization by insulin. J. Bioi. Chem. 1995; 270:
20801-7.
23 Tjomme VDB, Paul TMK, Jan AMR et 01. Cytokine priming
of the respiratory burst in human eosinophils is Ca 2+
independent and accompanied by induction of tyrosine
kinase activity. J. Leukoc. Bioi. 1993; 53: 347-53.
